Fierce Pharma
SEPTEMBER 11, 2024
Johnson & Johnson already has a major presence in the crowded inflammatory bowel disease (IBD) space with its popular Stelara. | Tremfya will enter the UC space as J&J’s older Stelara, which is approved to treat both forms of IBD, nears biosimilar competition and Inflation Reduction Act-mandated price concessions.
MedCity News
SEPTEMBER 11, 2024
More than 330 provider organizations signed letters this week urging the White House and Congress to extend a pandemic-era telehealth prescribing flexibility. Failure to extend this policy would cause millions of Americans to lose access to treatment, they argued. The post 300+ Provider Organizations Urge Feds to Prevent Leaked DEA Rule From Going into Effect appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
SEPTEMBER 11, 2024
For Intercept Pharmaceuticals’ beleaguered liver disease drug Ocaliva, the hits just keep coming. | Ahead of an advisory committee meeting slated for Friday, the FDA unleashed damning briefing documents calling into question the effectiveness and safety of Intercept’s rare liver disease drug Ocaliva. The regulator specifically raised an eyebrow at the post-marketing trials Intercept has used in a bid to keep hold of the accelerated approval it won back in 2016.
Pharma IQ
SEPTEMBER 11, 2024
Explore how the pharmaceutical industry is addressing its carbon footprint through sustainable sourcing, supply chain decarbonization, and data-driven strategy.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
SEPTEMBER 11, 2024
More than two years after an initial FDA approval in melanoma, Bristol Myers Squibb is moving its PD-1/LAG-3 combo Opdualag into registrational testing in one of the most important oncology disease | More than two years after an initial FDA approval in melanoma, Bristol Myers Squibb is moving its PD-1/LAG-3 combo Opdualag into registrational testing in one of the most important disease areas—first-line non-small cell lung cancer.
MedCity News
SEPTEMBER 11, 2024
More than 4 million Highmark commercial members now have access to AppliedVR’s RelieVRx as a covered therapeutic. The post Highmark Covers AppliedVR’s Product for Chronic Low Back Pain appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
SEPTEMBER 11, 2024
A machine-learning tool developed by AstraZeneca and trained on UK Biobank data, called MILTON, can predict over 1,000 diseases, before diagnosis
Fierce Pharma
SEPTEMBER 11, 2024
Last week, Zydus Lifesciences confirmed the receipt of an FDA warning letter at its Waghodia plant in Gujarat, India, marking the latest in a string of production reprimands for the India | Last week, Zydus Lifesciences confirmed the receipt of an FDA Warning Letter at its Waghodia plant in Gujarat, India, marking the latest in a string of production reprimands for the Indian drugmaker.
MedCity News
SEPTEMBER 11, 2024
By surfacing conversational, behavioral, and environmental insights at the point of care — and enabling data-driven operational decisions — AI has the power to transform individual patient experiences and drive systemic improvements in care quality and efficiency. The post The New Role of Engagement: Surfacing Insights at the Point of Care and Beyond appeared first on MedCity News.
Fierce Pharma
SEPTEMBER 11, 2024
Sanofi and Regeneron’s superstar anti-inflammatory biologic Dupixent is on a roll. | It was a busy day for Sanofi and Regeneron as the Dupixent partners look to expand the reach of Dupixent into several new diseases.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
European Pharmaceutical Review
SEPTEMBER 11, 2024
Sanofi has inaugurated a new production unit in France which utilises a world-first modular concept. The site, Modulus, located in Neuville-sur-Saône (Rhône-Alpes), is supported by an investment of nearly €500 million and will produce Sanofi’s next vaccines and biologic drugs. Modulus can adapt to manufacture up to four vaccines simultaneously. Notably, reconfiguration of the technological platform (live attenuated viral vaccines, recombinant protein or messenger RNA vaccines, as well as treatme
Pharmaceutical Technology
SEPTEMBER 11, 2024
As the approval date for Bristol Myers Squibb’s schizophrenia drug KarXT looms, a prodrug approach emerges to potentially address dosing challenges.
MedCity News
SEPTEMBER 11, 2024
Securities regulators say the role of Ipsen employee Dishant Gupta made him privy to details of the Epizyme acquisition. Gupta allegedly accumulated Epizyme shares while the deal was negotiated, then sold all of them hours after the transaction was announced. The post SEC Charges Ipsen Worker for Insider Trading Tied to $247M Epizyme Acquisition appeared first on MedCity News.
pharmaphorum
SEPTEMBER 11, 2024
One in two UK doctors would not use GenAI to treat patients, but there was more willingness to use it for diagnostic purposes, survey finds
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
PharmaVoice
SEPTEMBER 11, 2024
A broader approach recognizes the challenges disproportionately impacting women and could lead to better outcomes, according to Organon.
Pharmaceutical Commerce
SEPTEMBER 11, 2024
The parties’ want to provide customers with a “one-stop-shop,” with the hopes that their services will be easier to navigate.
MedCity News
SEPTEMBER 11, 2024
HLTH 2024, scheduled for October 20-23 at the Venetian Expo Center in Las Vegas, will highlight new programming, a physicians roundtable, generative AI, the shifting landscapes of telemedicine, retail health, women’s health, and lots more. The post Get Ready for HLTH 2024: A Preview Guide appeared first on MedCity News.
PharmaTech
SEPTEMBER 11, 2024
During a presentation at the PDA/FDA Joint Regulatory Conference, Nicholas Violand of Johnson & Johnson and Paul Palmer of Paul R. Palmer Limited discussed how aging facilities can impact the quality of pharmaceutical products.
MedCity News
SEPTEMBER 11, 2024
A direct-to-patient model for observational research will ease the participation burden, better incorporate the patient voice, and empower individuals to take control of their health – all while meeting the growing demands for robust evidence in developing new drugs and therapeutics. The post A Tailor-made Approach to Simplify Observational Research appeared first on MedCity News.
pharmaphorum
SEPTEMBER 11, 2024
Viridian's thyroid eye disease drug veligrotug clears its first phase 3 trial, with data suggesting it could be competitive with Amgen's Tepezza
Pharmaceutical Technology
SEPTEMBER 11, 2024
EASD 2024 participants are looking for the hottest efficacy data to make predictions on the next trend in the metabolic space.
PharmaTimes
SEPTEMBER 11, 2024
Patients with relapsed multiple myeloma gain access to life-extending therapy
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
PharmaVoice
SEPTEMBER 11, 2024
A handful of potential blockbusters are marching toward FDA review.
PharmaTimes
SEPTEMBER 11, 2024
New evidence highlights AI’s potential in early lung cancer detection
Clarivate
SEPTEMBER 11, 2024
September is World Alzheimer’s Month , a global campaign led by Alzheimer’s Disease International with the support of pharmaceutical companies involved in Alzheimer’s research. The campaign aims to raise awareness of the disease, which afflicts an estimated 416 million people worldwide, and challenge the stigma that persists around all types of dementia.
pharmaphorum
SEPTEMBER 11, 2024
A clinical trial has backed the safety and efficacy of Novo Nordisk's weight-loss drug Saxenda in children as young as six with obesity.
Pharmaceutical Commerce
SEPTEMBER 11, 2024
The latest news for pharma industry insiders.
pharmaphorum
SEPTEMBER 11, 2024
Roivant reveals its latest company, Pulmovant, which will develop a pulmonary hypertension drug licensed from Bayer in a $294m deal.
PharmaTech
SEPTEMBER 11, 2024
Solid form screening (SFS) is highly customizable based on the phase of the drug development life cycle, and collaborating with an expert solid form team will help accelerate your timelines and reduce costs. Not to mention, understanding the solid forms of your API will set you up for regulatory success. In this case study, Lonza’s SFS team collaborated with a drug sponsor to help select their lead form from three polymorphs and design a base crystallization process that met regulatory complianc
Evolve Your Success
SEPTEMBER 11, 2024
Anne Saulnier, the trailblazing CEO of Hex IQ, joins us to reveal how reimbursement data is revolutionizing healthcare sales. With her unique expertise in both marketing and enterprise software, Anne sheds light on the groundbreaking changes brought about by the 2020 law that mandates insurance companies to disclose negotiated rates. This newfound transparency empowers medical sales reps to showcase ROI compellingly, target the right customers, and accelerate their sales cycles.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
258 
Let's personalize your content